Who
Shannon Campbell
Director
Company insider
Files Form 4 as: Director, Black Diamond Therapeutics; Director, Zentalis Pharmaceuticals.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 10 Apr 2024
- Last trade
- 26 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 29 Jun 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 Jun 2026filed 29 Jun 2026 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 26 May 2026filed 27 May 2026 | ZNTL Zentalis PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —114,200 at $0.00 | filing |
| 26 May 2026filed 27 May 2026 | ZNTL Zentalis PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —114,200 at $0.00 | filing |
| 12 Jun 2025filed 12 Jun 2025 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,550 at $0.00 | filing |
| 13 Dec 2024filed 16 Dec 2024 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K4,500 at $2.50 | filing |
| 20 Sep 2024filed 20 Sep 2024 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $11K2,354 at $4.78 | filing |
| 21 Jun 2024filed 21 Jun 2024 | BDTX Black Diamond TherapeuticsBiotechnology | SEC FORM 4 Code A | $10K2,011 at $4.98 | filing |
| 6 Jun 2024filed 6 Jun 2024 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,550 at $0.00 | filing |
| 10 Apr 2024filed 12 Apr 2024 | BDTX Black Diamond Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,100 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.